The Expanding Global Footprint of Burkholderia pseudomallei and Melioidosis

Bart J Currie^{1

2}, Ella M Meumann^{1

2

3}, Mirjam Kaestli¹

Affiliations

¹ Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
² Infectious Diseases Department, Royal Darwin Hospital and Northern Territory Medical Program, Darwin, Northern Territory, Australia.
³ Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.

Editorial

Bart J Currie et al. Am J Trop Med Hyg. 2023.

. 2023 May 9;108(6):1081-1083.

doi: 10.4269/ajtmh.23-0223. Print 2023 Jun 7.

Bart J Currie^{1

2}, Ella M Meumann^{1

2

3}, Mirjam Kaestli¹

¹ Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
² Infectious Diseases Department, Royal Darwin Hospital and Northern Territory Medical Program, Darwin, Northern Territory, Australia.
³ Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.

No abstract available

References

1. Limmathurotsakul D. et al., 2016. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 1: 15008. - PubMed
1. Dance DAB, 1991. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4: 52–60. - PMC - PubMed
1. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ, 2010. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 82: 1113–1117. - PMC - PubMed
1. Currie BJ. et al., 2021. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. Lancet Infect Dis 21: 1737–1746. - PubMed
1. Currie BJ, 2015. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 36: 111–125. - PubMed